Gilead, Generics Co. Beat HIV Drug Antitrust Suit For Now
By Dorothy Atkins · August 29, 2023, 3:51 PM EDT
A California federal judge tossed a proposed class action alleging Gilead paid off generic HIV drugmakers to delay market entry, finding the consumers' claims they were harmed are too speculative, but...
To view the full article, register now.